Kura Oncology Financials - Benzinga

Kura Oncology Inc

KURANASDAQ

Trade with Public

Trade with Public

$9.57

0.293.13%

At close: Aug 6, 5:00 PM EST

$9.64

0.363.88%

Pre-Market: 8:00 AM EST

Earnings: Q2 2026 earnings tomorrow on Wed Aug 12th after the market close

Conference Call: Conference call scheduled tomorrow at 4:30 PM

Click to view the webcast

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Kura Oncology Financials

Kura Oncology (KURA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Kura Oncology Q1 EPS $(0.83) Beats $(0.94) Estimate, Sales $18.265M Miss $18.513M Estimate

Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.83) per share which beat the analyst consensus estimate of $(0.94) by 11.7 percent. This is a 25.76 percent decrease over losses of $(0.66) per share from the

Benzinga Newsdesk

Earnings Scheduled For May 12, 2026

Benzinga Insights

Kura Oncology Q4 Earnings Summary & Key Takeaways

Benzinga Insights

PRO
Kura Oncology Q4 EPS $(0.92) Misses $(0.59) Estimate, Sales $17.336M Miss $53.554M Estimate

Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.59) by 56.2 percent. This is a 318.18 percent decrease over losses of $(0.22) per share from

Benzinga Newsdesk

Earnings Scheduled For March 5, 2026

Benzinga Insights

A Glimpse of Kura Oncology's Earnings Potential

Benzinga Insights